VPIM
TVGN icon

Vanguard Personalized Indexing Management’s Tevogen Bio Holdings TVGN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-323
Closed -$20.2K – 2060
2025
Q2 		$20.2K Sell
323
-37
-10% -$2.11K ﹤0.01% 1907
2025
Q1 		$19.5K Buy
360
+67
+23% +$4.41K ﹤0.01% 1775
2024
Q4 		$15.1K Buy
+293
New +$19.1K ﹤0.01% 1785

Other funds holding TVGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Vanguard Personalized Indexing Management's TVGN Position: Q3 2025 in Review

Vanguard Personalized Indexing Management sold out of Tevogen Bio Holdings (TVGN) in Q3 2025, closing a stake of 323 shares — an estimated $20.2K sold.

Vanguard Personalized Indexing Management first reported a position in TVGN in Q4 2024 and held it in 3 quarters. The position peaked at $20.2K in Q2 2025. 54 funds tracked by Wall St. Rank hold TVGN as of Q3 2025.

  • Vanguard Personalized Indexing Management reported no remaining Tevogen Bio Holdings position as of Q3 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 323 Tevogen Bio Holdings shares in Q3 2025, an estimated $20.2K.
  • Vanguard Personalized Indexing Management first reported a position in Tevogen Bio Holdings in Q4 2024 and held it in 3 quarters.
  • Vanguard Personalized Indexing Management's Tevogen Bio Holdings position peaked at $20.2K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q3 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2025, filed 31 Oct 2025.